Cornell Law Review: Is More Information Always Better? Mandatory Disclosure Regulations in the Prescription Drug Market

Cornell Law Review: Is More Information Always Better? Mandatory Disclosure Regulations in the Prescription Drug Market

Despite the growing number of mandatory disclosure regulations, there is no theoretical or empirical reason to believe they are essential to ensure that health plan sponsors pay a competitive price for PBM services.